Bulltick Wealth Management LLC Purchases 4,801 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• Bulltick Wealth Management LLC increased its stake in UnitedHealth Group by 152%, acquiring an additional 4,801 shares, bringing its total holdings to 7,960 shares, now valued at approximately $4.17 million.
• UnitedHealth Group reported a Q2 earnings per share (EPS) of $4.08, missing analysts' estimates by $0.37, despite a 12.9% year-over-year revenue increase to approximately $111.62 billion.
• The company announced a dividend increase to $2.21 per share, yielding around 3.5%, which reflects a payout ratio of 38.3%.

Bulltick Wealth Management LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 152.0% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,960 shares of the healthcare conglomerate's stock after buying an additional 4,801 shares during the period. UnitedHealth Group comprises about 1.1% of Bulltick Wealth Management LLC's portfolio, making the stock its 29th biggest position. Bulltick Wealth Management LLC's holdings in UnitedHealth Group were worth $4,169,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Financial Management Professionals Inc. grew its holdings in UnitedHealth Group by 0.8% in the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock valued at $1,165,000 after buying an additional 17 shares during the last quarter. Global Wealth Strategies & Associates grew its holdings in UnitedHealth Group by 28.6% in the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock valued at $47,000 after buying an additional 20 shares during the last quarter. Kolinsky Wealth Management LLC lifted its position in shares of UnitedHealth Group by 1.0% in the 4th quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock worth $1,080,000 after acquiring an additional 21 shares during the period. Retirement Planning Group LLC lifted its position in shares of UnitedHealth Group by 5.1% in the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock worth $225,000 after acquiring an additional 21 shares during the period. Finally, Net Worth Advisory Group lifted its position in shares of UnitedHealth Group by 0.6% in the 1st quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate's stock worth $1,907,000 after acquiring an additional 21 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CEO Stephen J. Hemsley bought 86,700 shares of UnitedHealth Group stock in a transaction on Friday, May 16th. The shares were purchased at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the acquisition, the chief executive officer owned 679,493 shares in the company, valued at $196,081,295.01. This trade represents a 14.63% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. This represents a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders have acquired a total of 109,408 shares of company stock valued at $31,607,768 over the last ninety days. 0.28% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

UNH has been the subject of several analyst reports. Bank of America cut their target price on UnitedHealth Group from $350.00 to $300.00 and set a "neutral" rating for the company in a research report on Tuesday, July 29th. Mizuho cut their target price on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. Baird R W downgraded UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. HSBC restated a "reduce" rating and set a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Finally, Oppenheimer cut their price objective on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a research report on Wednesday, July 30th. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $366.52.

UnitedHealth Group Stock Up 3.7%

Shares of UnitedHealth Group stock traded up $9.22 during trading on Tuesday, reaching $261.59. The stock had a trading volume of 12,160,581 shares, compared to its average volume of 18,478,328. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a market capitalization of $237.30 billion, a price-to-earnings ratio of 11.33, a P/E/G ratio of 1.63 and a beta of 0.43. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a fifty day moving average price of $289.94 and a two-hundred day moving average price of $402.24.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The business's revenue was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $6.80 EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a dividend of $2.21 per share. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 3.4%. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.